Aided by rising Asian sales, medical devices supplier Swissray Global Healthcare Holding Ltd (SRG, 環瑞醫控股) yesterday said it aims to swing to profitability next year.
The company posted a loss of NT$399.08 million (US$12.9 million), or NT$3.16 per share, in the first three quarters of the year because of higher research and development (R&D) costs and marketing expenses.
That compares with a loss of NT$157.75 million, or NT$1.8 per share, a year ago, Swissray said in a filing with the Taiwan Stock Exchange.
Chief executive Jack Lee (李典忠) said spending on R&D and to promote its products in the Middle East, Russia and more Asian markets would continue next year, but Swissray’s bottom line should improve as sales grow.
Swissray expects to report double-digit annual revenue growth next year, after two of its X-ray imaging systems and its Norland bone densitometer were approved for sale in China this year, Lee said.
Swissray chairman Lee Tsu-der (李祖德) suggested that annual shipments would double next year.
From January through last month, Swissray reported a revenue of NT$492.89 million, up 83.65 percent from NT$224.51 million a year ago.
Its eponymous X-ray machines accounted for 23 percent of its revenue of NT$426.37 million in the first nine months of the year, while Norland bone densitometers contributed 9.2 percent and Novadaq molecular imaging products 5.1 percent, Swissray said.
Equipment maintenance revenue accounted for 62.7 percent of its sales during the period, down from 75.68 percent a year ago, it said.
Its long-term goal is to make its Swissray, Novadaq and Norland products provide 70 percent of total revenue, Jack Lee said.
The company was founded last year. Lee Tsu-der had acquired Switzerland-based X-ray machine maker Swissray Medical AG in March 2011, with its technology knowhow and access to retail channels in Europe and the US.
To expand its portfolio, Swissray acquired Norland’s bone densitometer assets from US-based medical and surgical device provider Cooper Surgical Inc last year, and contracted with Canadian medical device maker Novadaq Technologies Inc in November last year to distribute its products in 10 Asian nations, it said.
“Our strategy is to use products of renowned brands to enter Asian markets,” Lee Tsu-der said.
Asian sales provided 20 percent of its revenue in the past three quarters, it said.
It is set to shift its listing to the GRETAI Securities Market on Dec. 23, issuing 160 million shares, said Will Tsai (蔡揚威), Swissray’s executive assistant to the chairman, adding that the company has not yet set the share price.
Singapore-based ride-hailing and delivery giant Grab Holdings Ltd has applied for regulatory approval to acquire the Taiwan operations of Germany-based Delivery Hero SE's Foodpanda in a deal valued at about US$600 million. Grab submitted the filing to the Fair Trade Commission on Friday last week, with the transaction subject to regulatory review and approval, the company said in a statement yesterday. Its independent governance structure would help foster a healthy and competitive market in Taiwan if the deal is approved, Grab said. Grab, which is listed on the NASDAQ, said in the filing that US-based Uber Technologies Inc holds about 13 percent of
The domestic unit of the Chinese-owned, Dutch-headquartered chipmaker Nexperia BV will soon be able to produce semiconductors locally within China, according to two company sources. Nexperia is at the center of a global tug-of-war over critical semiconductor technology, with a Dutch court in February ordering a probe into alleged mismanagement at the company. The geopolitical tussle has disrupted supply chains, with some carmakers reportedly forced to cut production due to chip shortages. Local production would allow Nexperia’s domestic arm, Nexperia Semiconductors (China) Ltd (安世半導體中國), to bypass restrictions in place since October on the supply of silicon wafers — etched with tiny components to
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday received government approval to deploy its advanced 3-nanometer (3nm) process at its second fab currently under construction in Japan, the Ministry of Economic Affairs said in a news release. The ministry green-lit the plan for the facility in Kumamoto, which is scheduled to start installing equipment and come online in 2028 with a monthly production capacity of 15,000 12-inch wafers, the ministry said. The Department of Investment Review in June 2024 authorized a US$5.26 billion investment for the facility, slated to manufacture 6- to 12nm chips, significantly less advanced than 3nm process. At a meeting with
Taiwan’s food delivery market could undergo a major shift if Singapore-based Grab Holdings Ltd completes its planned acquisition of Delivery Hero SE’s Foodpanda business in Taiwan, industry experts said. Grab on Monday last week announced it would acquire Foodpanda’s Taiwan operations for US$600 million. The deal is expected to be finalized in the second half of this year, with Grab aiming to complete user migration to its platform by the first half of next year. A duopoly between Uber Eats and Foodpanda dominates Taiwan’s delivery market, a structure that has remained intact since the Fair Trade Commission (FTC) blocked Uber Technologies Inc’s
RSS